1. Home
  2. MRAM vs ENTA Comparison

MRAM vs ENTA Comparison

Compare MRAM & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$9.34

Market Cap

214.4M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$16.77

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ENTA
Founded
2008
1995
Country
United States
United States
Employees
87
120
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.4M
486.3M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
MRAM
ENTA
Price
$9.34
$16.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$10.50
$20.40
AVG Volume (30 Days)
153.0K
367.2K
Earning Date
11-05-2025
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,642,000.00
$65,324,000.00
Revenue This Year
$11.00
$0.99
Revenue Next Year
$9.39
$0.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$4.09
52 Week High
$12.27
$17.05

Technical Indicators

Market Signals
Indicator
MRAM
ENTA
Relative Strength Index (RSI) 55.59 71.71
Support Level $8.38 $14.07
Resistance Level $9.55 $17.05
Average True Range (ATR) 0.42 0.91
MACD 0.07 0.12
Stochastic Oscillator 69.21 89.70

Price Performance

Historical Comparison
MRAM
ENTA

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: